EP1472287A4 - PROTEIN FIXING RHAMNOSE - Google Patents

PROTEIN FIXING RHAMNOSE

Info

Publication number
EP1472287A4
EP1472287A4 EP03700718A EP03700718A EP1472287A4 EP 1472287 A4 EP1472287 A4 EP 1472287A4 EP 03700718 A EP03700718 A EP 03700718A EP 03700718 A EP03700718 A EP 03700718A EP 1472287 A4 EP1472287 A4 EP 1472287A4
Authority
EP
European Patent Office
Prior art keywords
binding protein
rhamnose
rhamnose binding
protein
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP03700718A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1472287A1 (en
Inventor
Richard J Lipscombe
Stephen John Carter
Michael Ruane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solbec Pharmaceuticals Ltd
Original Assignee
Solbec Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solbec Pharmaceuticals Ltd filed Critical Solbec Pharmaceuticals Ltd
Publication of EP1472287A1 publication Critical patent/EP1472287A1/en
Publication of EP1472287A4 publication Critical patent/EP1472287A4/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP03700718A 2002-02-07 2003-02-07 PROTEIN FIXING RHAMNOSE Ceased EP1472287A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPS036402 2002-02-07
AUPS0364A AUPS036402A0 (en) 2002-02-07 2002-02-07 Rhamnose binding protein
PCT/AU2003/000135 WO2003066679A1 (en) 2002-02-07 2003-02-07 Rhamnose binding protein

Publications (2)

Publication Number Publication Date
EP1472287A1 EP1472287A1 (en) 2004-11-03
EP1472287A4 true EP1472287A4 (en) 2005-10-05

Family

ID=3833965

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03700718A Ceased EP1472287A4 (en) 2002-02-07 2003-02-07 PROTEIN FIXING RHAMNOSE

Country Status (8)

Country Link
EP (1) EP1472287A4 (ja)
JP (1) JP2005538931A (ja)
CN (1) CN1639191A (ja)
AU (1) AUPS036402A0 (ja)
CA (1) CA2475066A1 (ja)
HK (1) HK1080089A1 (ja)
NZ (1) NZ534485A (ja)
WO (1) WO2003066679A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
WO2009040726A2 (en) * 2007-09-24 2009-04-02 Universite De Geneve Rhamnose antagonists and use thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHAM B E ET AL: "SOLASODINE GLYCOSIDES. SELECTIVE CYTOTOXICITY FOR CANCER CELLS AND INHIBITION OF CYTOTOXICITY BY RHAMNOSE IN MICE WITH SARCOMA 180", CANCER LETTERS, NEW YORK, NY, US, vol. 55, 1990, pages 221 - 225, XP002950613, ISSN: 0304-3835 *
CHAM B E ET AL: "TOPICAL TREATMENT OF MALIGNANT AND PREMALIGNANT SKIN LESIONS BY VERY LOW CONCENTRATIONS OF A STANDARD MIXTURE (BEC) OF SOLASODINE GLYCOSIDES", CANCER LETTERS, NEW YORK, NY, US, vol. 59, 1991, pages 183 - 192, XP001077064, ISSN: 0304-3835 *
LIN J-Y ET AL: "ISOLATION OF ANTI TUMOR PROTEINS ABRIN A AND ABRIN B FROM ABRUS-PRECATORIUS", INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, vol. 12, no. 5, 1978, pages 311 - 317, XP009051887, ISSN: 0367-8377 *
NICOLSON G L ET AL: "Characterization of two plant lectins from Ricinus communis and their quantitative interaction with a murine lymphoma", BIOCHEMISTRY 1974, vol. 13, no. 1, 1974, pages 196 - 204, XP002339396 *
See also references of WO03066679A1 *

Also Published As

Publication number Publication date
JP2005538931A (ja) 2005-12-22
CA2475066A1 (en) 2003-08-14
EP1472287A1 (en) 2004-11-03
CN1639191A (zh) 2005-07-13
WO2003066679A1 (en) 2003-08-14
NZ534485A (en) 2006-09-29
AUPS036402A0 (en) 2002-02-28
HK1080089A1 (zh) 2006-04-21

Similar Documents

Publication Publication Date Title
HK1080089A1 (zh) 鼠李糖結合蛋白
GB0208089D0 (en) Protein
GB0201808D0 (en) Protein
PL376318A1 (en) Protein modification
AU2003278718A8 (en) Stars-a muscle-specification-binding protein
GB0202748D0 (en) Protein
GB0204735D0 (en) Protein
GB0126888D0 (en) Binding protein
GB0208278D0 (en) Protein
GB0207470D0 (en) Protein
GB0202668D0 (en) Protein
GB0203165D0 (en) Protein
GB0212185D0 (en) Protein
GB0211830D0 (en) Protein
GB0211671D0 (en) Protein
GB0210141D0 (en) Protein
GB0210140D0 (en) Protein
GB0209621D0 (en) Protein
GB0204476D0 (en) Protein
GB0209488D0 (en) Protein
GB0209157D0 (en) Protein
GB0202666D0 (en) Protein
GB0208091D0 (en) Protein
GB0203167D0 (en) Protein
GB0208068D0 (en) Protein

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040813

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

A4 Supplementary search report drawn up and despatched

Effective date: 20050819

17Q First examination report despatched

Effective date: 20051107

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20090916